COBRE Notice of Special Funding Opportunity

The COBRE on Opioids and Overdose aims to increase the quantity and quality of research that aims to address the overdose crisis in Rhode Island. One means of attaining this goal is by identifying and nurturing talented junior investigators and enabling established investigators to pursue a new research line. The Pilot Program supports the COBRE’s growth by encouraging additional scholarship in the COBRE’s thematic areas and developing potential new COBRE Project Leaders at Rhode Island Hospital.

VIEW FULL PROGRAM DESCRIPTION

The goal of the COBRE on Opioids and Overdose is to develop research infrastructure in the area of opioids and overdose and provide Junior Investigators with formal mentoring and research project funding to help them acquire preliminary data and successfully compete for independent research grant support.

COBRE Awards are available to Junior Investigators and post-doctoral fellows at all Rhode Island-based higher educational institutions, research centers and hospitals. We seek to support a portfolio of compelling biomedical interdisciplinary research projects with potential for future NIH or other competitive funding.

The COBRE on Opioids and Overdose offers Junior Investigator Project Awards, Pilot Project Awards, and micro-grants for research related to the mission of the COBRE grant. Each award is contingent upon the availability of funding.

Research Project Leader Award Program

Research Project Leader Awards support Investigators who are doing opioid related research.  The Research Project Leader Award provides mentorship to ensure transition to independent R01 level-funding. Funding for this award ranges from $100,000 to $180,000 in direct costs. Our current Research Project Leader FOA can be found here.

Pilot Project Leader Award Program

The COBRE Pilot Project Leader Award seeks to support Investigators who are interested in opioid related research and seeks to form new collaborations. The program encourages post-doctoral fellows ready to make the transition to junior faculty positions and encourages cross-disciplinary, inter-institutional research collaborations. Funding ranges from $40,000 to $60,000 in direct costs.

Applications can be submitted on April 15th and October 15. Date restrictions can be overridden with recommendation from a COBRE Faculty member. Our current Pilot Project Leader FOA can be found here.

We encourage interested applicants to submit a project summary/scope statement and Other Support Documentation to Heather Wunschel at hwunschel@lifespan.org before beginning the application process for any award to ensure the proposed research fits with the mission of the COBRE.

COBRE Faculty are available to meet with applicants to discuss how to strengthen an application. Email Heather Wunschel at hwunschel@lifespan.org to schedule a phone call.

Other Funding Opportunities and Resources

The COBRE on Opioids and Overdose tracks opioid and overdose related funding opportunities nationally. We also connect researchers with other local COBRE funding and grant writing opportunities. If you have Rhode island-based funding opportunities or substance misuse related opportunities you would like us to post, please contact Heather Wunschel at hwunschel@lifespan.org.

Research Project Leaders

The COBRE on Opioids and Overdose offers a unique and innovative mentoring strategy that, in addition to primary project advising, will provide COBRE-funded Research Project Leaders specialized mentorship and services, empowering investigators to influence policy and practice through their research.

Learn More

Pilot Project Leaders

The COBRE on Opioids and Overdose aims to increase the quantity and quality of research in the area of opioids and overdose in Rhode Island.

Learn More

Other Funding Opportunities and Resources

Opioid and Substance misuse related funding opportunities (Updated bi-monthly) and Rhode Island IDeA Programs.

Learn More
© 2022 Opioid COBRE | Rhode Island Hospital
This website is supported by the COBRE on Opioids and Overdose funded by the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM125507. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.